Adrián Chapa‐Rodríguez

OverviewAI-generated summary

Adrián Chapa‐Rodríguez's research focuses on the role of SLAMF1 in nonalcoholic fatty liver disease (NAFLD). His work has demonstrated that SLAMF1 is expressed and secreted by hepatocytes and the liver. Further investigations indicate that SLAMF1 mediates hepatocyte death in models of non-alcoholic steatohepatitis (NASH). Chapa‐Rodríguez has also explored the transition of care for patients with eosinophilic gastrointestinal diseases, identifying challenges and opportunities within this process. His scholarship metrics include an h-index of 8, with 19 total publications and 863 total citations.

Metrics

• h-index: 8
• Publications: 19
• Citations: 863